BMEA Insider Transactions
41 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 1–41; provenance stays internal.
BMEA insiders transaction timeline
PurchaseSale
| Insider profile | Role | Date | Transaction | Shares | Price |
|---|---|---|---|---|---|
| Erdtmann Rainer M | See Remarks | 2025-12-11 | Purchase | 30,000.0 | $1.43 |
| Hitchcock Michael J.M. | Interim CEO | 2025-12-02 | Purchase | 100,000.0 | $0.99 |
| Erdtmann Rainer M | See Remarks | 2025-12-01 | Purchase | 10,000.0 | $1.05 |
| Erdtmann Rainer M | See Remarks | 2025-11-28 | Purchase | 40,000.0 | $1.1 |
| Hitchcock Michael J.M. | Director | 2024-09-30 | Purchase | 10,000.0 | $10.06 |
| Valle Franco | Chief Financial Officer | 2024-06-11 | Purchase | 12,509.0 | $4.43 |
| A2A Pharmaceuticals, Inc. | TenPercentOwner | 2023-06-01 | Sale | 50,000.0 | $34.56 |
| A2A Pharmaceuticals, Inc. | TenPercentOwner | 2023-05-31 | Sale | 75,000.0 | $33.81 |
| A2A Pharmaceuticals, Inc. | TenPercentOwner | 2023-05-12 | Sale | 25,000.0 | $33.84 |
| A2A Pharmaceuticals, Inc. | TenPercentOwner | 2023-05-09 | Sale | 150,000.0 | $34.5 |
| A2A Pharmaceuticals, Inc. | TenPercentOwner | 2023-05-08 | Sale | 100,000.0 | $33.99 |
| A2A Pharmaceuticals, Inc. | TenPercentOwner | 2023-04-20 | Sale | 200,000.0 | $29.12 |
| A2A Pharmaceuticals, Inc. | TenPercentOwner | 2023-03-31 | Sale | 200,000.0 | $31.25 |
| A2A Pharmaceuticals, Inc. | TenPercentOwner | 2023-03-31 | Sale | 200,000.0 | $31.25 |
| Cormorant Asset Management, LP | TenPercentOwner | 2023-03-30 | Purchase | 400,000.0 | $30.0 |
| Chen Bihua | Director,TenPercentOwner | 2023-03-30 | Purchase | 400,000.0 | $30.0 |
| Cormorant Global Healthcare Master Fund, LP | TenPercentOwner | 2023-03-30 | Purchase | 400,000.0 | $30.0 |
| Cormorant Private Healthcare Fund III LP | TenPercentOwner | 2023-03-30 | Purchase | 400,000.0 | $30.0 |
| Hitchcock Michael J.M. | Director | 2022-11-14 | Purchase | 5,000.0 | $7.93 |
| Valle Franco | Chief Financial Officer | 2022-11-11 | Purchase | 4,100.0 | $7.63 |
| A2A Pharmaceuticals, Inc. | TenPercentOwner | 2022-08-16 | Purchase | 30,684.0 | $13.87 |
| A2A Pharmaceuticals, Inc. | TenPercentOwner | 2022-07-21 | Sale | 34,658.0 | $11.21 |
| A2A Pharmaceuticals, Inc. | TenPercentOwner | 2022-06-24 | Sale | 34,658.0 | $11.76 |
| Valle Franco | Chief Financial Officer | 2022-01-14 | Purchase | 10,000.0 | $8.68 |
| A2A Pharmaceuticals, Inc. | TenPercentOwner | 2021-09-17 | Purchase | 34,658.0 | $10.96 |
| Stergiopoulos Sotirios | Director | 2021-09-17 | Purchase | 34,658.0 | $10.96 |
| Erdtmann Rainer M | President & COO | 2021-08-23 | Purchase | 24,000.0 | $13.2 |
| Butler Thomas Andrew | CEO | 2021-08-23 | Purchase | 24,000.0 | $13.2 |
| Erdtmann Rainer M | President & COO | 2021-08-18 | Purchase | 14,000.0 | $10.77 |
| Butler Thomas Andrew | CEO | 2021-08-18 | Purchase | 14,000.0 | $10.77 |
| Erdtmann Rainer M | President & COO | 2021-08-17 | Purchase | 14,000.0 | $10.79 |
| Butler Thomas Andrew | CEO | 2021-08-17 | Purchase | 14,000.0 | $10.79 |
| Cormorant Asset Management, LP | TenPercentOwner | 2021-04-20 | Purchase | 900,000.0 | $17.0 |
| Chen Bihua | Director | 2021-04-20 | Purchase | 900,000.0 | $17.0 |
| Cormorant Global Healthcare Master Fund, LP | TenPercentOwner | 2021-04-20 | Purchase | 900,000.0 | $17.0 |
| Cormorant Private Healthcare Fund III LP | TenPercentOwner | 2021-04-20 | Purchase | 900,000.0 | $17.0 |
| Erdtmann Rainer M | President and COO | 2021-04-15 | Purchase | 3,000.0 | $17.0 |
| Erdtmann Rainer M | President and COO | 2021-04-15 | Purchase | 3,000.0 | $17.0 |
| Erdtmann Rainer M | President and COO | 2021-04-15 | Purchase | 2,400.0 | $17.0 |
| Erdtmann Rainer M | President & COO | 2021-04-15 | Purchase | 176,470.0 | $17.0 |
| Butler Thomas Andrew | CEO | 2021-04-15 | Purchase | 176,470.0 | $17.0 |